UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 23, 2006
IMMERSION CORPORATION
(Exact name of registrant as specified in its charter)
------------------------
Delaware 000-27969 94-3180138
----------------------------- ------------------------ -------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
------------------------
801 Fox Lane
San Jose, California 95131
(Address of principal executive offices) (Zip Code)
------------------------
Registrant's telephone number, including area code: (408) 467-1900
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On May 25, 2006, Immersion Medical, Inc., a wholly-owned subsidiary of
Immersion Corporation, ("Immersion Medical"), and Richard Vogel, the Senior Vice
President and General Manager of Immersion Medical, agreed upon and executed an
amendment to Mr. Vogel's employment agreement. This amendment extends Mr.
Vogel's right to receive the severance benefits set forth in his employment
agreement beyond the original two year term. These severance benefits include
the continued payment of Mr. Vogel's salary at his final base salary rate, less
applicable withholding, for six months following the termination of his
employment without cause. The amendment also allows Mr. Vogel to develop certain
inventions related to wound care on his own time without Immersion Medical
owning such inventions. A copy of the amendment to Mr. Vogel's employment
agreement is attached hereto as Exhibit 10.66 and is incorporated herein by
reference.
Item 9.01 Financial Statement and Exhibits.
(d) Exhibits.
Exhibit Number Exhibit Title or Description
-------------- ------------------------------------------------------
10.66 Amendment No. #1 to Employment Agreement dated May 25,
2006, by and between Immersion Medical, Inc. and
Richard Vogel.
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
IMMERSION CORPORATION
Date: May 26, 2006 By: /s/ Stephen M. Ambler
--------------------------------
Stephen M. Ambler
Chief Financial Officer and Vice
President, Finance
EXHIBIT INDEX
-------------
Exhibit No. Description
----------- -----------
10.66 Amendment No. #1 to Employment Agreement dated May 23, 2006, by
and between Immersion Medical, Inc. and Richard Vogel.